VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Conditional survival in patients with chronic myeloid leukemia in chronic phase in the era of tyrosine kinase inhibitors.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Conditional survival in patients with chronic myeloid leukemia in chronic phase in the era of tyrosine kinase inhibitors.
Conditional survival in patients with chronic myeloid leukemia in chronic phase in the era of tyrosine kinase inhibitors. Cancer. 2016 Jan 15; 122(2):238-48.
View in:
PubMed
subject areas
Adolescent
Adult
Age Factors
Aged
Aged, 80 and over
Analysis of Variance
Dasatinib
Disease-Free Survival
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Humans
Imatinib Mesylate
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Leukemia, Myeloid, Chronic-Phase
Male
Middle Aged
Multivariate Analysis
Predictive Value of Tests
Prospective Studies
Protein Kinase Inhibitors
Randomized Controlled Trials as Topic
Severity of Illness Index
Sex Factors
Survival Analysis
Treatment Outcome
Young Adult
authors with profiles
HAGOP M KANTARJIAN
JORGE E CORTES
MARINA KONOPLEVA
ELIAS JOSEPH JABBOUR
GAUTAM BORTHAKUR
NAVEEN PEMMARAJU
NAVAL DAVER
KOICHI TAKAHASHI